$AMGN

Amgen Inc

Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Thousand Oaks, CA

AMGN chart

What traders are saying about $AMGN

Latest posts

Amgen Inc news

Amgen Inc key financials

USD2025202420232022
Revenue$36.75B$33.42B$28.19B$26.32B
Net income$7.71B$4.09B$6.72B$6.55B
Diluted EPS$14.23$7.56$12.49$12.11
Total assets (year end)$90.59B$91.84B$97.15B$65.12B
Cash and equivalents (year end)$9.13B$11.97B$10.94B$7.63B

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Amgen Inc

Ticker
AMGN (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Thousand Oaks, CA
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
318154

Frequently asked questions

What exchange is Amgen Inc listed on?

Amgen Inc trades on the Nasdaq under the ticker symbol AMGN.

What industry is Amgen Inc in?

Amgen Inc is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.

Where is Amgen Inc headquartered?

Amgen Inc's business address on file with the SEC is in Thousand Oaks, CA.

When does Amgen Inc's fiscal year end?

Amgen Inc's fiscal year ends on December 31.

How much revenue did Amgen Inc report?

Amgen Inc reported $36.75B in revenue for calendar year 2025, according to its SEC filings.